Axsome Therapeutics
AXSM
AXSM
30 hedge funds and large institutions have $33.3M invested in Axsome Therapeutics in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 10
Holders
30
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$796K | |
| 2 | +$278K | |
| 3 | +$186K | |
| 4 |
JPMorgan Chase & Co
New York
|
+$128K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$119K |
Top Sellers
| 1 | -$1.26M | |
| 2 | -$880K | |
| 3 | -$372K | |
| 4 |
ECM
Element Capital Management
New York
|
-$338K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$269K |